Home / Inspections / 993873

FDA Inspection 993873 — Smithfield Bioscience Inc

Smithfield Bioscience Inc — FEI 1527761

The FDA completed an inspection of Smithfield Bioscience Inc on October 27, 2016 in Cincinnati, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 27, 2016
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cincinnati, OH (United States)

Facility

Other inspections at this facility

  • 1297264 (OAI Tue Dec 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1174658 (VAI Fri Jul 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1091136 (VAI Wed May 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 905867 (VAI Fri Nov 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 784068 (VAI Fri May 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

  • Seizure (10788) (Thu Nov 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources